KIA
RDY icon

KLR Investment Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

KLR Investment Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-33,025
Closed -$376K – 197
2023
Q3 		$376K Buy
+33,025
New +$447K 0.34% 94
2023
Q2 		– Sell
-34,415
Closed -$392K – 185
2023
Q1 		$392K Buy
+34,415
New +$371K 0.34% 96

Other funds holding RDY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

KLR Investment Advisors's RDY Position: Q4 2023 in Review

KLR Investment Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q4 2023, closing a stake of 33,025 shares — an estimated $376K sold.

KLR Investment Advisors first reported a position in RDY in Q1 2023 and held it in 2 quarters. The position peaked at $392K in Q1 2023. 224 funds tracked by Wall St. Rank hold RDY as of Q4 2023.

  • KLR Investment Advisors reported no remaining Dr. Reddy's Laboratories position as of Q4 2023 after selling out during the quarter.
  • KLR Investment Advisors sold 33,025 Dr. Reddy's Laboratories shares in Q4 2023, an estimated $376K.
  • KLR Investment Advisors first reported a position in Dr. Reddy's Laboratories in Q1 2023 and held it in 2 quarters.
  • KLR Investment Advisors's Dr. Reddy's Laboratories position peaked at $392K in Q1 2023.
  • 224 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2023.

Based on KLR Investment Advisors's 13F filing for Q4 2023, filed 8 Feb 2024.